Volume 11, Issue 1 (2026)                   SJMR 2026, 11(1): 5-11 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nateghi M R, Sanaye Naderi M, Mohammadian H. A Review of The Causes, Pathophysiological Mechanisms and Clinical Consequences of Second-Trimester Breakthrough Bleeding (BTB). SJMR 2026; 11 (1) : 2
URL: http://saremjrm.com/article-1-387-en.html
1- Sarem Gynecology, Obstetrics and Infertility Research Center, Sarem Women’s Hospital, Iran University of Medical Science (IUMS), Tehran, Iran. & Sarem Cell Research Center (SCRC), Sarem Women’s Hospital, Tehran, Iran.
2- Sarem Gynecology, Obstetrics and Infertility Research Center, Sarem Women’s Hospital, Iran University of Medical Sciences, Tehran, Iran. & Sarem Cell Research Center (SCRC), Sarem Women’s Hospital, Tehran, Iran.
3- Sarem Gynecology, Obstetrics and Infertility Research Center, Sarem Women’s Hospital, Iran University of Medical Sciences, Tehran, Iran.
Abstract:   (24 Views)
Bleeding during pregnancy is a major clinical challenge and can range from benign to life-threatening for both maternal and fetus. In the second trimester, breakthrough bleeding (abnormal vaginal bleeding in the presence of an ongoing normal pregnancy and in the absence of signs of labor or miscarriage) is a relatively rare but significant phenomenon.
Possible causes include hormonal changes, cervical abnormalities, early placental lesions, or damage to the decidua. Given the lack of scientific literature focused on BTB in this period of pregnancy, a comprehensive review and analysis of the available literature is necessary to clarify the underlying factors and clinical management.
Article number: 2
Full-Text [PDF 363 kb]   (9 Downloads)    
Article Type: Analytical Review | Subject: Pregnancy Care
Received: 2026/04/18 | Accepted: 2026/05/2 | Published: 2026/06/3

References
1. Chollet, C., Andre, B., Voglimacci, M., Ghassani, A., Parant, O., & Guerby, P. (2020). Perinatal outcomes of second trimester antenatal genital bleeding. Clinical and Experimental Obstetrics & Gynecology, 47(1), 105-110. [DOI:10.31083/j.ceog.2020.01.5112]
2. Koifman, A., Levy, A., Zaulan, Y., Harlev, A., Mazor, M., Wiznitzer, A., & Sheiner, E. (2008). The clinical significance of bleeding during the second trimester of pregnancy. Archives of Gynecology and Obstetrics, 278(1), 47-51. https://doi.org/10.1007/s00404-007-0530-2 [DOI:10.1007/s00404-007-0529-6] [PMID]
3. Parant, O., Clouet-Delannoy, M., Connan, L., Duclusaud, A., Chale, J. J., & Fournié, A. (2000). Vaginal bleeding during the second trimester of pregnancy: Obstetrical and perinatal outcome. A retrospective study including 85 cases. Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 29(1), 66-72.
4. Musilova, I., Stranik, J., Jacobsson, B., & Kacerovsky, M. (2024). Antibiotic treatment reduces the intensity of intraamniotic inflammation in pregnancies with idiopathic vaginal bleeding in the second trimester of pregnancy. American Journal of Obstetrics & Gynecology, 230(2), 245.e1-245.e14. [DOI:10.1016/j.ajog.2023.07.041] [PMID]
5. Signore, C. C., Sood, A. K., & Richards, D. S. (1998). Second-trimester vaginal bleeding: Correlation of ultrasonographic findings with perinatal outcome. American Journal of Obstetrics & Gynecology, 178(2), 336-340. https://doi.org/10.1016/S0002-9378(98)80022-7 [DOI:10.1016/S0002-9378(98)80021-4] [PMID]
6. James AH, Pacheco LD, Konkle BA. Management of pregnant women who have bleeding disorders. Hematology Am Soc Hematol Educ Program. 2023;2023(1):229-242. [DOI:10.1182/hematology.2023000475] [PMID] []
7. Karim SA, Bakhtawar I, Butta AT, Jalil M. Effects of first and second trimester vaginal bleeding on pregnancy outcome. J Pak Med Assoc. 1998;48(2):40-42.
8. American College of Obstetricians and Gynecologists. Management of preterm labor. ACOG Practice Bulletin No. 171. Obstet Gynecol. 2016;128(4):e155-64. [DOI:10.1097/AOG.0000000000001711] [PMID]
9. American College of Obstetricians and Gynecologists' Committee on Obstetric Practice; Society for Maternal-Fetal Medicine. Magnesium sulfate before anticipated preterm birth for neuroprotection. Committee Opinion No. 455. Obstet Gynecol. 2010;115(3):669-71. [DOI:10.1097/AOG.0b013e3181d4ffa5] [PMID]

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2026 CC BY-NC 4.0 | {Sarem Journal of Medical Research}

Designed & Developed by : Yektaweb